American IVD Market: Competitive Dynamics & Global Outlook 2025

Addressing the most sought-after questions that occupy the minds of entrepreneurs and decision makers, the new report of "Stratview Research" on the American IVD Market, answers all the important questions.

Getting to the bare bones of the issues and factors which are sculpturing the market, Stratview Research brings out the best actionable market intelligence for the global American IVD Market.

The analysts have scrupulously studied the trend and cautiously forecasted the future market developments for 2019-2025.
The important questions the report answers are:
1. What will be the market growth rate in the near future?
2. What are the major developments in the market wrt regulations, acquisitions and innovations?
3. What are the growth drivers as well as the constraints?
4. What are the regional growth hotspots?
5. What are the segmental growth forecasts?

These questions and many more, big and small, are all discussed in the report in great detail.

The American In Vitro Diagnostics (IVD) Market Insights
North America is the biggest IVD market globally, and is also the biggest consumption market. The San Francisco Bay Area may be often considered as a natural home to well established IVD device leaders responsible for spearheading industry advancements including Bio-Rad, Roche and Thermo Fisher and many other promising startups breaking into the market. Currently it has approximately 30% share of the global market and would exceed the share by 2020, growing at a CAGR of 3.57% from 2019 till 2025.

American In Vitro Diagnostics Market Segmentation
Central and South America
• By Long Term Growth Forecast
• By Products and Services (2018-2025) (Equipment, Reagents, Services, etc)
• By Technology (2018-2025) (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
• By Therapeutic Area (2018-2025) (Tropical Diseases, Lifestyle Disease, Neurology, Oncology, etc)
• By End User (2018-2025) (Hospital, Hospital Bed Side, Home Users, Research Labs)
• By Domestic Versus Global Competition
• By Key Export/Import Destinations
Mexican IVD Market – Long Term Growth Forecast (2018e-2025f)
• By Products & Services (Equipment, Reagents, Services, etc)
• By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
• By Therapeutic Area (Tropical Diseases, Lifestyle Disease, Neurology, Oncology, etc)
• By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
• By Domestic Competition
• By Global Competition
• Are You Planning To Invest in 2019-2020?
Argentina's IVD Market – Long Term Growth Forecast (2018e-2025f)
• By Products & Services (Equipment, Reagents, Services, etc)
• By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
• By Therapeutic Area (Tropical Diseases, Lifestyle Disease, Neurology, Oncology, etc)
• By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
• By Domestic Competition
• By Global Competition
• Are You Planning To Invest in 2019-2020?
Brazil's IVD Market – Long Term Growth Forecast (2018e-2025f)
• By Products & Services (Equipment, Reagents, Services, etc)
• By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
• By Therapeutic Area (Tropical Diseases, Lifestyle Disease, Neurology, Oncology, etc)
• By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
• By Domestic Competition
• By Global Competition
• Are You Planning To Invest in 2019-2020?
Peru's IVD Market – Long Term Growth Forecast (2018e-2025f)
• By Products & Services (Equipment, Reagents, Services, etc)
• By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
• By Therapeutic Area (Tropical Diseases, Lifestyle Disease, Neurology, Oncology, etc)
• By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
• By Domestic Competition
• By Global Competition
• Are You Planning To Invest in 2019-2020?
North America
• By Long Term Growth Forecast
• By Products and Services (2018-2025) (Equipment, Reagents, Services, etc)
o Top Three Opportunistic Segments
• By Technology (2018-2025) (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
o Top Three Opportunistic Segments
• By Therapeutic Area (2018-2025) (Tropical Diseases, Lifestyle Disease, Neurology, Oncology, etc)
o Top Three Opportunistic Segments
• By End User (2018-2025) (Hospital, Hospital Bed Side, Home Users, Research Labs)
o Top Three Opportunistic Segments
• By Domestic Versus Global Competition
• By Key Export/Import Destinations
The USA's IVD Market – Long Term Growth Forecast (2018e-2025f)
• By Products & Services (Equipment, Reagents, Services, etc)
• By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
• By Therapeutic Area (Infectious Diseases, Lifestyle Disease, Neurology, Oncology, etc)
• By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
• By Domestic Versus Global Competition
• By Global Competition
• Are You Planning To Invest in 2019-2020?
Canada's IVD Market – Long Term Growth Forecast (2018e-2025f)
• By Products & Services (Equipment, Reagents, Services, etc)
• By Technology (Immunology, Molecular Diagnostics, POCT, Microbiology, Hematology, etc)
• By Therapeutic Area (Infectious Diseases, Lifestyle Disease, Neurology, Oncology, etc)
• By End User (Hospital, Hospital Bed Side, Home Users, Research Labs)
• By Domestic Competition
• By Global Competition
• Are You Planning To Invest in 2019-2020?

Get a free sample of the report:
https://www.stratviewresearch.com/Request-Sample/458/in-vitro-diagnostic-ivd-market-in-america.html

Market Segments
In North America, some of the most common routine tests that are conducted in laboratories include cholesterol level tests, HIV tests, pap tests, pregnancy tests, tests to detect infectious diseases and substance abuse tests. Clinical lab testing is also used to monitor other diseases and drug treatments. Specialty testing, which are often more expensive than routine tests, cover tests in genetics, immunology, oncology, endocrinology, and other segments. The clinical laboratory market is highly competitive with hundreds of providers. North America has a presence of some of the major global players in the world that are headquartered in USA.
Convenient Centers are the new IVD Walk-in Clinics in North America especially the United States. As per the growing trend in 2017-2018, IVD service providers, such as Quest Diagnostics (Quest) and Laboratory Corporation of America (LabCorp) and few other laboratories have been actively promoting patient service centers in grocery stores and retail pharmacies. In 2017, Quest had announced plans to open patient services centers with several retailers, particularly in the states of Texas and Florida. Similarly, LabCorp disclosed an agreement with the Walgreens Boots Alliance.
The US is one of the leaders in the market, which is moving towards value-based model, there are few clinical laboratories in the southwestern United States which are looking at how to prevent early term delivery. The San Francisco Bay Area is home to well-established IVD device leaders responsible for spearheading industry advancements including Bio-Rad, Roche and Thermo Fisher and many other promising startups breaking into the market.
Compared to North, Central and South American IVD market enjoys a little over 3% of the global IVD market share. Although the market is small, with limited resources and infrastructure, but it offers opportunities in the form of high disease presence (which requires testing), medical tourism (Peru, Brazil, Argentina get high traffic from USA every year). The report from Stratview research also looks at the smaller market in South America such as Peru while including the bigger markets such as Mexico, Argentina and Brazil.
In South America, markets vary depending on the demand from the population, for e.g. In the Brazilian IVD market, 77% of the population rely on the public healthcare system, which makes it challenging for the government to expand its services and reduce the exam time. While in Central America, if we consider markets such as Mexico, the scenario is different and we observe them as early adopters of technology. Public laboratories are subsidized by the government and usually acquire molecular diagnostics (MolDx) equipment through reagent rentals rather than outright purchases. This is variable in the private laboratories, but purchasing methods are more dependent on the workload, the type of instrument and the decision makers (typically including the laboratory director and governing board in private laboratories and purchasing departments in public laboratories).

Click Here for Other Reports from Stratview Research in the Advanced materials Industry:
https://www.stratviewresearch.com/market-reports/Healthcare-and-Life-Sciences.html

Stratview Research
400 Renaissance Center,
Suite 2600,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
sales@stratviewresearch.com

Stratview Research is a global market intelligence firm offering a wide range of services including syndicated market reports, consulting, sourcing intelligence, and customer research. We are a trusted brand in the research industry with capability of commissioning complex projects within a short span of time with high level of accuracy.

This release was published on openPR.